期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Post-translational modification of Parkin and its research progress in cancer 被引量:2
1
作者 Dan Ding Xiang Ao +5 位作者 Ying Liu yuan-yong wang Hong-Ge Fa Meng-Yu wang Yu-Qi He Jian-Xun wang 《Cancer Communications》 SCIE 2019年第1期655-664,共10页
Clinical practice has shown that Parkin is the major causative gene found in an autosomal recessive juvenile parkin-sonism(AR-JP)via Parkin mutations and that the Parkin protein is the core expression product of the P... Clinical practice has shown that Parkin is the major causative gene found in an autosomal recessive juvenile parkin-sonism(AR-JP)via Parkin mutations and that the Parkin protein is the core expression product of the Parkin gene,which itself belongs to an E3 ubiquitin ligase.Since the discovery of the Parkin gene in the late 1990s,researchers in many countries have begun extensive research on this gene and found that in addition to AR-JP,the Parkin gene is associated with many diseases,including type 2 diabetes,leprosy,Alzheimer’s,autism,and cancer.Recent studies have found that the loss or dysfunction of Parkin has a certain relationship with tumorigenesis.In general,the Parkin gene,a well-established tumor suppressor,is deficient and mutated in a variety of malignancies.Parkin overexpres-sion inhibits tumor cell growth and promotes apoptosis.However,the functions of Parkin in tumorigenesis and its regulatory mechanisms are still not fully understood.This article describes the structure,functions,and post-transla-tional modifications of Parkin,and summarizes the recent advances in the tumor suppressive function of Parkin and its underlying mechanisms. 展开更多
关键词 PARKIN E3 ubiquitin ligase CANCER Post-translational modification Parkin/PTEN-induced kinase 1(PINK1) NIP3-like protein X UBIQUITINATION SUMOYLATION NEDDYLATION Phosphorylation
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部